NEVANAC

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug NEVANAC contains one active pharmaceutical ingredient (API):

1	Nepafenac UNII 0J9L7J6V8C - NEPAFENAC
	Nepafenac is a non-steroidal anti-inflammatory and analgesic prodrug. After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Amfenac inhibits the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production.
	Read more about Nepafenac

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEVANAC Eye drops, suspension	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC10	Nepafenac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500904901132312, 526514120079903
CA	Health Products and Food Branch	02308983
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.817-08-07
EE	Ravimiamet	1343001, 1614822
ES	Centro de información online de medicamentos de la AEMPS	07433001, 07433001IP, 107433002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	126949, 141063, 195092
GB	Medicines & Healthcare Products Regulatory Agency	155115, 345804, 375246
HK	Department of Health Drug Office	57847
IL	מִשְׂרַד הַבְּרִיאוּת	7007
IT	Agenzia del Farmaco	038813010, 038813022, 038813034
JP	医薬品医療機器総合機構	1319759Q1026
LT	Valstybinė vaistų kontrolės tarnyba	1029815, 1074076, 1075476
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	329M2006
NG	Registered Drug Product Database	B4-3535
Switch country to Nigeria in order to find specific presentations of NEVANAC
NL	Z-Index G-Standaard, PRK	106755
PL	Rejestru Produktów Leczniczych	100143311, 100201824
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64477001, W64478001
SG	Health Sciences Authority	13759P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504710151, 8699504710205
US	FDA, National Drug Code	0065-0002
ZA	Health Products Regulatory Authority	42/15.4/1006